Lv, X., Mi, D. M., Xin, Y., Dong, W., & Wang, D. (2025). Sodium-Glucose Transport Protein-2 Inhibitors in the Treatment of Non-alcoholic Steatohepatitis: An Evidence-Based Review. Hepatitis Monthly, 25(1), 1. https://doi.org/10.5812/hepatmon-153404
Chicago Style (17th ed.) CitationLv, Xueyan, Dianchao Mi Mi, Yuhang Xin, Wei Dong, and Dongmei Wang. "Sodium-Glucose Transport Protein-2 Inhibitors in the Treatment of Non-alcoholic Steatohepatitis: An Evidence-Based Review." Hepatitis Monthly 25, no. 1 (2025): 1. https://doi.org/10.5812/hepatmon-153404.
MLA (9th ed.) CitationLv, Xueyan, et al. "Sodium-Glucose Transport Protein-2 Inhibitors in the Treatment of Non-alcoholic Steatohepatitis: An Evidence-Based Review." Hepatitis Monthly, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.5812/hepatmon-153404.